BRIC-RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY

Today, an MoU was signed between the Rajiv Gandhi Centre for Biotechnology (#BRIC-RGCB) and Cochin Cancer Centre, Kochi (CCRC) on cancer research and advanced diagnostics. Professor Chandrabhas Narayana, Director of RGCB, and Dr. Balagopal P.G., Director of CCRC, signed the MoU on behalf of RGCB and CCRC in the presence of Shri Pinarayi Vijayan, Hon'ble Chief Minister, Kerala State, Smt. Veena George, Hon'ble Minister of Health & Family Welfare, Govt. Kerala, and Shri P. Rajeev, Hon'ble Minister of Law and Industries, Govt. Kerala Department of Biotechnology

To mitigate the problem of #AMR, BRIC RGCB - Rajiv Gandhi Centre for Biotechnology is developing new candidate drugs for AMR Priority Pathogens. Large chemical libraries are being screened for phenotypic characterization to study mode of action and target identification. #DBTfightsAMR Rajesh Gokhale

Dr. Malini Laloraya (former faculty, BRIC-RGCB) felicitated during the conference "Pioneering the Future of Healthcare and Diagnostics using 4D Omics" held at IIT Bombay on 12th November 2024. Dr. Laloraya was among the scientists selected for a special session, "Honoring Women Pioneers: Transforming Science and Society." Dr. Laloraya also delivered a talk entitled "Revolutionizing Reproductive Health: Omics Approaches in Female Metabolism." Congratulations to Dr. Malini Laloraya. Department of Biotechnology

A new publication from the laboratory of Dr. Jackson James (Scientist, Neuro Biology and Regenerative Biology Program, #RGCB) appeared in the journal " iScience"and the title of the manuscript is "TLX3 regulates CGN progenitor proliferation during cerebellum development and its dysfunction can lead to autism". This is the first paper from BRIC-RGCB have single-cell sequencing data done in house 10X platform. The manuscript can be accessed from https://lnkd.in/g7ju29jn

Dr Jackson James (Scientist G, Neurobiology & Regenerative Biology Program, #RGCB) is elected as a Fellow of the Indian Academy of Neurosciences. This was announced during the recently concluded XLII Annual Meeting of the Indian Academy of Neurosciences (IAN) held at NIMHANS, Bengaluru, from 11-14th November 2024. Hearty congratulations to Dr Jackson James To learn more about the ongoing research program at Dr. Jackson's laboratory, please visit https://lnkd.in/gvBNv7kn

Honoring the legacy of tribal leader and freedom fighter Dharti Aaba Bhagwan Birsa Munda on his 150th birth anniversary, celebrated as Janjatiya Gaurav Diwas across the nation. # JanjatiyaGauravDiwas

A new publication from Prof. M. Radhakrishna Pillai (Former Director, RGCB) & Dr. Devasena Ananatharaman (scientist, Cancer Research Program, RGCB) appeared in the journal "Journal of the National Cancer Institute Monographs," and the title of the manuscript is "A prospective cohort study comparing efficacy of 1 dose of quadrivalent human papillomavirus vaccine to 2 and 3 doses at an average follow-up of 12 years post vaccinations." The manuscript can be accessed from https://lnkd.in/gTEFE-TR Department of Biotechnology Radhakrishna Pillai, FRCPath, PhD, FAMS, FASc, FNASc,FNA

In the thrilling month of November 2008, the Rajiv Gandhi Centre for Biotechnology (RGCB) in Thiruvananthapuram set the stage for a groundbreaking international symposium on Human Papillomavirus-associated cancers, brilliantly titled "Translating Research into Cancer Prevention." The event attracted a dazzling array of luminaries in HPV biology, igniting a wave of innovation that would forever change the landscape of cancer prevention. From this prestigious gathering emerged RGCB's role as the laboratory host for the groundbreaking "two versus three dose vaccine" study, a pivotal research initiative that would take the world by storm. The state-of-the-art vaccine efficacy facility, bolstered by the support of the International Agency for Research Against Cancer (IARC), was inaugurated in 2009 by Dr. Christopher Wild, then Director of IARC. And thus, a remarkable journey began—one that would pave the way for revolutionary advancements in cancer prevention! The rest, as they say, is history!

Hands on Training on Mammalian Cell Culture And Application #RGCB is conducting a course on   Mammalian Cell Culture And Application   from 26 - 29 November 2024. Last Date of Registration: 22 November, 2024 For more details: https://lnkd.in/gciEYeTx For online application: https://lnkd.in/gXxaiMVx Department of Biotechnology

Hands on Training on Microscopy Techniques and Applications #RGCB is conducting a course on  Microscopy Techniques and Applications from 26 - 29 November 2024. Last Date of Registration: 22 November, 2024 For more details: https://lnkd.in/gQK7DkRH For online application: https://lnkd.in/gA53KugR Department of Biotechnology